Related Experiment Video

Updated: Jul 26, 2025

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.5K

A Safer Path to Cellular Rejuvenation: Endogenous Oct4 Activation via CRISPR/dCas9 in Progeria Mouse Models

Di Hu1, Enora Le Borgne1, Rico Meinl1

  • 1Retro Biosciences, Inc., San Francisco, California, USA.

Cellular Reprogramming
|June 16, 2023
PubMed

Insights

Activating Oct4 with CRISPR rejuvenates cells and extends lifespan in a progeria mouse model. This approach shows promise for treating aging diseases with reduced cancer risk compared to other methods.

Area of Science:

  • Molecular Biology
  • Genetics
  • Aging Research

Background:

  • Transient expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) can reverse aging phenotypes but carries oncogenic risks.
  • Concerns exist regarding the safety of therapeutic reprogramming factors, particularly c-Myc.

Discussion:

  • CRISPR/dCas9 activator system successfully induced endogenous Oct4 expression for cellular rejuvenation.
  • This method restored epigenetic patterns and reduced disease markers in a progeria mouse model.
  • Transient Oct4 activation demonstrated a lower incidence of cancer transformation than OSKM.

Key Insights:

  • Transcriptional activation of endogenous Oct4 is sufficient for cellular rejuvenation and lifespan extension.
  • CRISPR/dCas9-mediated Oct4 activation offers a safer alternative to OSKM for therapeutic applications.
  • The study highlights the potential of targeted gene activation in combating age-related diseases.

Outlook:

  • This approach may lead to novel therapeutic strategies for progeria and other age-related conditions.
  • Further research could explore the broader applications of CRISPR-based cellular reprogramming for rejuvenation.
  • Developing safer reprogramming techniques is crucial for advancing regenerative medicine.
Keywords:
CRISPR/dCas9Hutchinson–Gilford progeria syndromeagingendogenous Oct4

More Related Videos

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

9.6K
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.4K

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K